Theralase Technologies Inc. TLT.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.52% | 26.63% | 25.02% | -6.88% | 16.95% |
| Total Depreciation and Amortization | -17.30% | -4.85% | 6.53% | -3.99% | -9.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -62.18% | -37.60% | -63.50% | 41.51% | 94.45% |
| Change in Net Operating Assets | 4.80% | -25.51% | -428.91% | 113.98% | -151.14% |
| Cash from Operations | -20.81% | 27.46% | -156.08% | 50.38% | -148.21% |
| Capital Expenditure | 59.26% | 98.44% | 716.33% | -74.60% | -1,250.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 74.07% | 101.78% | 716.33% | -74.60% | -1,250.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 3.21% | -9.05% | 48.12% | -24.68% | -49.13% |
| Issuance of Common Stock | 464.80% | 258.14% | 126.09% | -48.78% | 31.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | 481.58% | 297.34% | 202.39% | -43.04% | 29.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5,076.54% | 726.70% | 268.43% | 134.76% | -126.94% |